BRIEF-Novartis Bioventures reports 11.8 pct passive stake in Ra Pharmaceuticals – SEC filing

* Novartis Bioventures Ltd reports 11.8 percent passive stake in Ra Pharmaceuticals Inc as of Oct. 31 - SEC filing Source text for Eikon: Further company coverage: ;))…
Read the full story: Reuters: Healthcare